Configuring SAML with Okta
Follow these instructions to configure Okta as your SAML IdP.
How to configure SAML with Okta
- Log in to the Okta Admin Console.
- On the menu bar, click Classic UI.
- In the Shortcuts menu, click Add Applications.
- In the left-hand panel, click Create New App.
- In the Create a New Application Integration dialog box, select SAML 2.0.
- Click Create.
- In the General Settings panel, in the App name field, type
FortiDLP
. - Click Next.
- In the Single sign on URL field, paste the ACS URL you obtained from the FortiDLP Console.
- In the Audience URI (SP Entity ID) field, paste the Entity ID you obtained from the FortiDLP Console.
- In the Attribute statements section, configure your attributes:
- To configure the login name attribute:
- In the Name field, type
Email
or your preferred login name attribute name. - In the corresponding Value menu, select user.email (leaving Name format set to Unspecified).
- In the Name field, type
- To configure the role attribute:
- Click Add Another.
- In the Name field, paste
https://jazznetworks.com/SAML/Attributes/Role
. - In the corresponding Value menu, select your preferred role attribute name (leaving Name format set to Unspecified). This can be an existing attribute or a new custom attribute you create using these instructions. The attribute value must correspond to at least one role in the FortiDLP Infrastructure.
- To configure first and last name attributes:
- In the Name field, type
FirstName
. - In the corresponding Value menu, select user.firstName (leaving Name format set to Unspecified).
- Click Add Another.
- In the Name field, type
LastName
. - In the corresponding Value menu, select user.lastName (leaving Name format set to Unspecified).
- In the Name field, type
- To configure the login name attribute:
- Click Next.
- Click Finish.
- In the Sign on methods panel, click View Setup Instructions.
- At the bottom of the page, in the Optional section, copy the IDP metadata.
To finish configuring SAML, see Configuring IdP metadata and attributes.